Skip to main content
EMV CAPITAL PLC logo

EMV CAPITAL PLC — Investor Relations & Filings

Ticker · EMVC ISIN · GB00BN4R5Q82 LEI · 213800N5WD46G1Y7I458 IL Financial and insurance activities
Open in API
Filings indexed 547 across all filing types
Latest filing 2014-07-29 Regulatory Filings
Country GB United Kingdom
Listing IL EMVC

About EMV CAPITAL PLC

https://www.emvcapital.com/

EMV Capital PLC is a venture capital investment group specializing in deep tech and life sciences. The firm identifies, invests in, and builds high-growth, IP-rich companies with an international portfolio, focusing on sectors including industrial technology, healthcare, and sustainability. It employs a capital-efficient investment strategy that combines syndicated investments, direct balance sheet funding, and managed funds to support companies from their early stages through to successful exit. EMV Capital engages in proactive portfolio management, often taking board positions and working closely with company leadership. It provides extensive value creation services, including support for fundraising, exit readiness, IP strategy, and corporate collaborations, to drive growth and maximize returns for investors through strategic exits.

Recent filings

Filing Released Lang Actions
NetScientific announces shareholder name change
Regulatory Filings Classification · 98% confidence The document is a short announcement (under 5,000 characters) issued via the London Stock Exchange's RNS (Regulatory News Service). It informs the market about a name change of a significant shareholder (Quantadyne Limited to White Mustard Investments). While it mentions a shareholder, it does not report a change in the percentage of ownership (threshold crossing), which would be an MRQ. Since it is a general regulatory announcement regarding company information that does not fit into specific categories like DIRS or MRQ, it falls under the RNS category.
2014-07-29 English
NetScientific Invests in Breakout Labs Companies
Regulatory Filings Classification · 100% confidence The document is an announcement from NetScientific PLC regarding new investments in two portfolio companies (G-Tech Medical and Longevity Biotech). It is distributed via the Regulatory News Service (RNS) of the London Stock Exchange. Since it is a corporate news announcement regarding business activities and does not fit into specific categories like financial reports, dividends, or director dealings, it falls under the general regulatory announcement category.
2014-07-23 English
TR1 - Notification of Major Interest in Shares
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' form, which is the standard regulatory template used in the UK for disclosing changes in significant share ownership (crossing thresholds). The content explicitly details the identity of the issuer (NetScientific plc), the person subject to the notification (Invesco Limited), and the resulting percentage of voting rights (33.42%). This aligns perfectly with the definition of a Major Shareholding Notification.
2014-07-21 English
TR1 - Notification of Major Interest in Shares
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' form, which is the standard regulatory template used in the UK for disclosing significant changes in share ownership (crossing thresholds). The content explicitly details the identity of the issuer (NetScientific plc), the person subject to the notification (Woodford Investment Management LLP), and the percentage of voting rights held (10.01%). This fits the definition of a Major Shareholding Notification.
2014-07-11 English
Notification of Major Interest In Shares
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' form, which is the standard regulatory filing in the UK for disclosing changes in significant share ownership (crossing the 3% threshold). This matches the definition for 'Major Shareholding Notification'.
2014-07-04 English
Research Programme in DNA Sequencing
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the Regulatory News Service (RNS) of the London Stock Exchange. It announces a new research programme in DNA sequencing for NetScientific PLC. Since it is a general corporate announcement regarding business operations and does not fit into specific categories like financial reports, M&A, or director dealings, it falls under the RNS (Regulatory Filings) category.
2014-07-02 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.